The tool "Ambroxol" the instruction describes as a mucolytic drug. The medicine has an expectorant effect. The medication has the ability to stimulate serous cells in the glands of the bronchial mucosa, increases the secretion volume, thereby changing the disturbed balance of the mucous and serous component in sputum. Due to the effect of the agent, activation of hydrolyzing enzymes is noted. The drug is also able to slightly suppress cough. After use, the agent is absorbed from the digestive tract almost completely.
After about 0.5-3 hours, the maximum concentration of the drug is noted. The tool is able to quickly distribute throughout the tissues in the body. The drug is found in milk, passes the BBB. The highest concentration of the drug is observed in the lungs.
Appointment
The medicine "Ambroxol", the instruction recommends for acute or chronic pathologies of the respiratory tract, complicated by the formation of sputum difficult to separate. In particular, it is indicated for bronchiectasis, bronchitis with obstructive syndrome, asthma. The drug is recommended for respiratory distress syndrome. The medication can be used from birth.
Side effects
Rarely, a medication provokes vomiting, nausea, pain in the abdomen, and diarrhea. Against the background of hypersensitivity, the appearance of angioedema, urticaria, and skin rash is likely. Other negative reactions include headache, general weakness.
Contraindications
Means "Ambroxol" the instruction does not allow for appointment with gastric ulcer, convulsive syndrome of various nature. The drug is not recommended for intolerance. Contraindications include the first trimester of the antenatal period.
Medication "Ambroxol". Instructions for use
Children under two years of age are prescribed twice a day, 7.5 mg each, up to five - the same dose three times. From 5 to 12 years old - 15 milligrams 2-3 r / d. For patients from the age of twelve, 30 mg is recommended twice or thrice a day. The drug "Ambroxol" (syrup for children), the instruction recommends prescribing in case of difficulty in swallowing tablets.
With respiratory distress syndrome, infants, including premature infants, are given parenteral medication. The dosage is calculated according to the weight of the child. Intramuscularly or intravenously, 10 mg / kg / d is administered with a frequency of 3-4 r / day. In severe cases, a dosage increase of up to 30 mg / kg / d is allowed. Treatment is carried out under the supervision of a physician. The dosage of the inhalation agent is set personally.
additional information
On the basis of bronchial asthma, to prevent the development of irritation in the respiratory tract before inhalation, bronchodilators are allowed. In the case of the appointment of the drug "Ambroxol" nursing should decide on the suspension of lactation. When using the drug in combination with antitussive medications, sputum transport is difficult. When combined with the drugs "Doxycycline", "Amoxicillin" or "Cefuroxime", their penetration into the secret of the bronchi is enhanced.